The TEM-and SHV-type extended-spectrum ␤-lactamases (ESBLs) are widely distributed among the Enterobacteriaceae (14) , with the latter being more prevalent in Asia (5) . In Japan, SHV-12 enzymes are found most frequently in Klebsiella pneumoniae and Escherichia coli (20, 22) . In contrast, there are a few reports describing the isolation of TEM-or SHV-type ESBLs in Pseudomonas aeruginosa (19) . In the Enterobacteriaceae, genes encoding SHV-type enzymes usually are located on plasmids (8) , whereas they are primarily chromosomally encoded in P. aeruginosa (2, 10, 11, 15) . We consider that the difference is one of the reasons that P. aeruginosa strains harboring genes for SHV-type enzymes are very rare. However, there has been only weak evidence for the insertion of these resistance determinants into the P. aeruginosa chromosome. In the present study, we identified the presence of an ESBL in P. aeruginosa isolates from a burn patient undergoing long-term intensive care. We explored the insertion sequences (IS) associated with these genes. Our investigations indicate that the P. aeruginosa isolates have acquired the ESBL gene during the clinical course.
Seven P. aeruginosa strains were isolated from a 27-year-old female patient (total burn surface area, 83%). Isolated strains, sites of infection, and antimicrobial treatments are summarized in Fig. 1 . All seven isolates were O-serotype E, which corresponds to the international antigenic scheme O11 (6) , as determined by a panel of typing antisera (Denka Seiken, Tokyo, Japan). Random amplified polymorphic DNA-PCR (RAPD-PCR), which was performed according to reference 9, showed closely similar patterns among all seven isolates (Fig.  2) . These suggested that they derived from the same clone.
MICs were determined basically by the microdilution method according to the proposal of the Clinical and Laboratory Standards Institute (CLSI) (3), except the concentration of clavulanic acid (CLA) was 2 g/ml according to Naas et al. (11) . Four of the seven isolates, which were obtained from the burn sites during the earlier stages of the clinical course (on admission or on the 20th clinical day) or from sputum, were susceptible to cephalosporins. However, the other three strains, isolated from the burn sites later in the clinical course (24th clinical day), exhibited a broad spectrum of resistance to expanded-spectrum cephalosporins, and their MICs decreased following the addition of CLA. In addition, these three strains simultaneously harbored resistance to amikacin (Table 1) .
PCR was performed using HotStaTaq polymerase master mix (Qiagen, Hilden, Germany). PCR analysis for SHV-type ESBLs (17) indicated that bla SHV was present in the three resistant strains, which had the bla SHV-12 nucleotide sequence, but not in the four susceptible strains. PCR analysis for insertion sequence 26 (IS26) (7) showed that the three resistant strains also contained the same IS26 elements, which were detected both upstream and downstream of bla , with the sequence between them being identical to part of plasmid pKPN4 (CP000649) (Fig. 3C) .
The determinations of the IS26 flanking sequences indicating the transposon insertion site were performed with TaKaRa LA PCR in vitro cloning kits (TaKaRa Ltd., Kyoto, Japan) using specific primer sets ( Table 2) . We identified a partial gene sequence downstream from IS26. The gene detected was PA5317, which encodes a probable binding protein component of an ABC dipeptide transporter in P. aeruginosa PAO1 (AE004091). We performed PCR amplifications with PA5317-specific primers (Table 2 ) spanning the insertion site. These analyses indicated that the insertions in PA5317 were found only in the three strains carrying bla SHV-12 ( Fig. 3A and B) . Furthermore, the 8-bp duplication of the target site was identified in these resistant strains following amplification with primers for PA5317 and the IS26 elements upstream and downstream of the insertion site.
The inserted transposon was Ͼ24 kb in size and contained at least five IS26 elements (Fig. 3C) . The first part of the transposon (4,453 bp) exhibited a sequence identical to that of the plasmid pKPN4 and contained the bla SHV-12 gene. The second and fourth parts (Ͼ6.5 kb and 3,526 bp, respectively) shared sequences identical to that of Yersinia pestis biovar Orientalis strain IP275 (NZ_AAOS02000011). The third part (Ͼ1.1 kb) showed a sequence identical to that of Salmonella enterica subsp. enterica serovar Newport strain SL254 plasmid pSN254 (NC_009140). The fifth part (4,367 bp) showed sequence similarity (81% identity) to Marinobacter aquaeolei VT8 (NC_008740), containing an integrase and aminoglycoside 6Ј-N-acetyltransferase type Ib [aac(6Ј)-Ib], which provided the aminoglycoside acetyltransferase activity responsible for the amikacin resistance (16) .
Our report is the first isolation of SHV-12-producing P. aeruginosa strains in Japan, and there is only one report concerning a PER-1-type ESBL-producing P. aeruginosa (21) . On the other hand, there are several reports of bla SHV -carrying P. aeruginosa, including the following: SHV-2a in France and Tunisia (1, 4, 10, 11), SHV-5 in Greece (12, 15) , SHV-12 in Thailand and Korea (2, 13) , and an unidentified SHV in Iran (18) .
The IS26 insertion sequence is widely distributed among the Enterobacteriaceae plasmids; on the other hand, only two studies have detected bla SHV associated with IS26 in P. aeruginosa (10, 11) . However, these studies did not examine the regions around the IS26 elements. The present study is the first reported identification of an IS26 insertion into the P. aeruginosa chromosome. The IS26 composite transposon inserted chromosomally into PA5317 and an 8-bp duplicate sequence (TTC CCGCC) was identified. Furthermore, it is possible that this insertion occurred during the clinical course, since the transposon was detected in only the three isolates taken from the burn area later in the course of treatment. The IS26 composite transposon was very large (Ͼ24 kb) and, like bla SHV-12 , it contained the antibiotic resistance gene aac(6Ј)-Ib, which causes amikacin resistance. The acquisition of the transposon appeared to occur immediately after amikacin administration and was not likely to be associated with ceftazidime (CAZ) treatment (Fig. 1) . Amikacin selection pressure was strongly suggested to contribute to the later prevalence of transposonpositive strains.
Several studies have suggested that P. aeruginosa represents a hidden reservoir for ESBLs (10, 11) . The present study indicates that P. aeruginosa and the Enterobacteriaceae use dif- A burn patient (27-year-old female) suffered from a total burn surface area of 83% and transferred to Sapporo Medical University Hospital on the fourth clinical day. All strains except P072204 were isolated from burn sites. P072204 was isolated from sputum. Arrows and bars indicate periods of antibiotic administration. PZFX, pazufloxacin; CZOP, cefozopran; DRPM, doripenem.
FIG. 2. RAPD-PCR analysis of P. aeruginosa isolates. RAPD-PCR
analyses were carried out using primer 272 or 208 (9) . Lanes 1 to 7 were isolates from the burn patient, and lanes 8 and 9 were serotype E strains isolated from other patients. Lanes: 1, P072201; 2, P072202; 3, P072203; 4, P072204; 5, P072205; 6, P072206; 7, P072207; 8, P070401; and 9, SP9715. , and it appears that transposons are more difficult to transmit than plasmids. However, we propose that careful attention be given to the transfer of these genes, especially with respect to the acquisition of multidrug resistance. Nucleotide sequence accession number. The sequences corresponding to the genetic elements described in this work were assigned the NCBI accession numbers GU592828 and GU592829.
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